Lucid Diagnostics' positive earnings report, with a beat on both EPS and sales estimates, is likely to instill investor confidence and could lead to a short-term uptick in the stock price. The substantial year-over-year growth in sales and reduced losses are key indicators of the company's improving financial health, which is typically rewarded by the market.